Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray repair cross complementing 6 pseudogene 2 (XRCC6P2) is a human pseudogene, meaning it is a DNA sequence that resembles a gene but is generally considered non-functional in producing a protein product[1][7]. XRCC6P2 is related by sequence to the XRCC6 gene, which encodes Ku70, a protein involved in DNA repair by non-homologous end joining[10]. However, XRCC6P2 itself does not produce a functional protein and is not described as having a known biological role or established disease relevance. It is not considered a therapeutic target, does not fit into major molecular classification families such as enzymes, receptors, or transcription factors, and has no established role in biological pathways or as a biomarker or drug target[1][7]. The name is sometimes confused with XRCC6, a bona fide DNA repair protein, but XRCC6P2 should not be classified as a functional gene or therapeutic target. Key Points: - XRCC6P2 is a pseudogene, not a functional gene or receptor[1][7]. - There is no evidence it is directly involved in disease, drug action, or biological function. - It is sometimes listed simply for its annotation and should not be mistaken for XRCC6 (Ku70), which does have DNA repair functions[10]. If you require information about the **functional XRCC6 gene/protein (Ku70)**, please clarify, as current entries reference the pseudogene XRCC6P2, which has no established function or targetability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray repair cross complementing 6 pseudogene 2 (XRCC6P2).